Glenmark recalls over 1 lakh bottles of Indomethacin capsules from US market

06 Apr 2018 Evaluate

Glenmark Pharmaceuticals has initiated recall of 109,080 bottles of anti-inflammatory Indomethacin capsules (USP, 50 mg, 100-count bottle) from the US market, due to incorrect instructions on the labeling.

Glenmark’s current portfolio consists of 131 products authorized for distribution in the US marketplace and 63 ANDA’s pending approval with the US FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharma Share Price

1934.25 -56.40 (-2.83%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×